Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2019

01-01-2019 | Concise Research Reports

Pap Testing in the USA and Potential Association with HPV Vaccination: a Cross-sectional Analysis of the BRFSS Data (2007–2016)

Authors: Dongyu Zhang, PhD, Xuezheng Sun, PhD

Published in: Journal of General Internal Medicine | Issue 1/2019

Login to get access

Excerpt

The US Preventive Services Task Force (USPSTF) recommends women aged 21–65 years should undergo Papanicolaou test (Pap test) every 3 years to prevent cervical cancer.1 However, no nationwide representative population-based research described Pap test use from a temporal perspective in the past decade. This brief report describes the temporal trend of Pap test use in the USA between 2007 and 2016. Considering that human papillomavirus (HPV) vaccination may affect screening behaviors, we further assessed the 10-year trend of HPV vaccination and its association with Pap test use. …
Literature
2.
go back to reference Doescher MP, Jackson JE. Trends in cervical and breast cancer screening practices among women in rural and urban areas of the United States. J Public Health Manag Pract 2009;15(3):200–209.CrossRef Doescher MP, Jackson JE. Trends in cervical and breast cancer screening practices among women in rural and urban areas of the United States. J Public Health Manag Pract 2009;15(3):200–209.CrossRef
Metadata
Title
Pap Testing in the USA and Potential Association with HPV Vaccination: a Cross-sectional Analysis of the BRFSS Data (2007–2016)
Authors
Dongyu Zhang, PhD
Xuezheng Sun, PhD
Publication date
01-01-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4652-y

Other articles of this Issue 1/2019

Journal of General Internal Medicine 1/2019 Go to the issue

Healing Arts: Materia Medica

Living Fully with Sickle Cell Disease

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.